Nomad Foods Q2 2026: Gross Margin Inflects Positively, but Volumes Slide 5.9%

What happened

Nomad Foods reported Q2 2026 results showing a 3.1% reported revenue decline to €724 million, with organic revenue down 2.9% driven by a 5.9% volume drop offset partially by 3.0% positive price/mix. Importantly, adjusted gross margin expanded by 110 basis points year-over-year, marking the first significant margin inflection after the 300-400 bps compression in 2025, as pricing and productivity gains began to offset input cost inflation. However, adjusted EBITDA still declined 4.3% to €124 million and adjusted EPS fell 2.5% to €0.39, indicating that the margin recovery has not yet translated into earnings growth due to the continued volume weakness and likely higher operating costs. CEO Dominic Brisby characterized the quarter as "an important step forward," emphasizing that cash generation remained strong with adjusted free cash flow conversion higher year-on-year. Against the backdrop of the previous DeepValue thesis, which had flagged H1-2026 checkpoints for organic revenue stabilization and gross margin improvement, this quarter delivers on margin but falls short on volume, sustaining the tension between price-led margin recovery and potential share loss.

Implication

Investors should view the Q2 results as a partial validation of the margin-recovery thesis, with adjusted gross margin improving above the 100 bps threshold, but the persistent organic revenue decline and accelerating volume fall (-5.9% vs -1.4% in Q3 2025) suggest the company is trading volume for margin. The failure to stabilize organic revenue at or above 0%—a key checkpoint from the prior report—increases the probability of the bear case where price increases alienate consumers and private label gains share. However, strong free cash flow conversion and the 3.0% price/mix contribution indicate that pricing power remains intact, and the efficiency program is beginning to show results. Therefore, investors should maintain a cautious stance, holding existing positions but not adding until evidence of volume stabilization or at least a moderation in volume declines appears in subsequent quarters. Any further deterioration in volume without corresponding margin gains would likely shift the thesis toward a bearish outcome, while a volume recovery would strongly support the bull case.

Thesis delta

The Q2 results partially validate the margin-recovery leg of the thesis, as adjusted gross margin improved 110 bps, exceeding the 100 bps threshold set in the original report. However, organic revenue remains negative at -2.9% and volume decline worsened to -5.9%, failing the revenue stabilization checkpoint and increasing the probability of the bear case where price increases lead to sustained share loss. Consequently, the investment thesis remains intact but with lower conviction on the growth assumption, shifting the balance slightly away from the base case toward the bear scenario.